Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.